These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9842444

  • 1. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ, Ruble DL, Zaucha GM, Jaax GP, Waag DM.
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [Abstract] [Full Text] [Related]

  • 2. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL, Elliott JJ, Waag DM, Jaax GP.
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [Abstract] [Full Text] [Related]

  • 3. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL, Waag DM.
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [Abstract] [Full Text] [Related]

  • 4. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J, Schramek S, Lisák V, Brezina R.
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC, Peacock MG, Race RE.
    Rev Elev Med Vet Pays Trop; 1993 Mar; 46(1-2):87-94. PubMed ID: 8134661
    [Abstract] [Full Text] [Related]

  • 7. Changes in spleen and thymus cell phenotypes in mice vaccinated with the Coxiella burnetii phase I whole-cell vaccine or the chloroform-methanol residue subunit vaccine.
    Waag DM, Williams JC.
    Acta Virol; 1996 Apr; 40(2):87-94. PubMed ID: 8886117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J, Votruba D, Propper P, Schramek S.
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM, England MJ, Pitt ML.
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [Abstract] [Full Text] [Related]

  • 11. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
    Zhang YX, Zhi N, Yu SR, Li QJ, Yu GQ, Zhang X.
    Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
    [Abstract] [Full Text] [Related]

  • 12. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH.
    Ann N Y Acad Sci; 1992 Jun 16; 653():88-111. PubMed ID: 1626897
    [Abstract] [Full Text] [Related]

  • 13. Biological properties of chloroform/methanol extracts of Coxiella Burnetii.
    Tokarevich NK, Daiter AB, Polotsky YE, Lukácová M, Kazár J, Kartseva NA, Kuzina VA, Efremov VE, Belov AG.
    Acta Virol; 1993 Feb 16; 37(1):29-40. PubMed ID: 8105650
    [Abstract] [Full Text] [Related]

  • 14. Standardized guinea pig model for Q fever vaccine reactogenicity.
    Baeten LA, Podell BK, Sluder AE, Garritsen A, Bowen RA, Poznansky MC.
    PLoS One; 2018 Feb 16; 13(10):e0205882. PubMed ID: 30312355
    [Abstract] [Full Text] [Related]

  • 15. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W, Wang P, Xiong X, Jiao J, Yang X, Wen B.
    PLoS One; 2015 Feb 16; 10(4):e0124664. PubMed ID: 25909586
    [Abstract] [Full Text] [Related]

  • 16. Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine.
    Peacock MG, Fiset P, Ormsbee RA, Wisseman CL.
    Acta Virol; 1979 Jan 16; 23(1):73-81. PubMed ID: 35962
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
    Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Banfield CM, Pitt ML.
    Vaccine; 2002 Jun 07; 20(19-20):2623-34. PubMed ID: 12057622
    [Abstract] [Full Text] [Related]

  • 19. [Delayed type hypersensitivity responses to recombinant mycobacterial antigen 38,000 in guinea pigs sensitized to Mycobacterium tuberculosis].
    He X, Zhuang Y, Zhang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar 07; 23(3):161-3. PubMed ID: 11778490
    [Abstract] [Full Text] [Related]

  • 20. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.
    Waag DM, England MJ, Bolt CR, Williams JC.
    Clin Vaccine Immunol; 2008 Oct 07; 15(10):1505-12. PubMed ID: 18701647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.